Target identification and assessment in the era of AI.
AI revolutionizes drug target identification, enhancing success rates and efficiency in clinical trials. ππ
April 21, 2026
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
AI-Driven Protein Design Enhances Development of Intracellular Antibodies
AI-driven protein design improves the creation of stable intracellular antibodies, aiding diagnostics and biomedical research. π§¬π¬
April 10, 2026
Blueprint for Drug Repurposing Success: Foundational Concepts and Practical Framework.
Exploring drug repurposing: faster approvals, AI integration, and innovative strategies. π§¬π
March 30, 2026
AI-Driven Design of Miniproteins as Potential Allosteric Modulators.
AI-Driven Miniproteins: Revolutionizing Allosteric Modulation in Drug Discovery π§¬π
March 29, 2026
Antimicrobial discovery from underexplored environments: unlocking specialized metabolism.
Exploring new antibiotic sources: AI, multi-omics, and ecology combat AMR crisis. π¦ π¬π
March 27, 2026
BioPathNet: A New AI Tool for Analyzing Biomedical Data Networks
BioPathNet is an AI tool for analyzing biomedical data networks, aiding in gene functions and disease mechanisms. π§¬π
March 19, 2026
Discovery of a novel compound against BmNPV using virtual screening based on the protein structure of the viral whole genome.
Novel antiviral compound identified against BmNPV using AI-driven virtual screening. Significant larval survival improvement observed. π¦π
March 15, 2026
DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets.
Revolutionary AI in Drug Design: DeepDegradome Enhances PROTAC Development with Higher Binding Affinity! ππ¬
March 13, 2026
MML-DTI: Multimanifold Learning with Hyperbolic Graph Neural Networks for Enhanced Drug-Target Interaction Prediction.
Revolutionary DTI prediction using hyperbolic geometry! π Enhanced accuracy through multimanifold learning and HGNN integration. π¬
March 10, 2026
Advances in Fragment-based Drug Design: Lessons and Innovations from the Post-COVID Drug Discovery Landscape.
Fragment-based drug design revolutionizes drug discovery, enhancing speed and efficiency post-COVID. Key insights from recent research. ππ¬
January 28, 2026